Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Prospective Trial of Telemedicine Based Remote Home Monitoring After Liver Transplantation
Brief Summary: A significant opportunity exists to involve patients and their caregivers in more effective perioperative care and transition to home for transplant patients. Stakeholders were engaged through the University of Cincinnati Liver Transplant Program to prioritize changes in improving post transplant care. The initial findings indicated that increasing "care between visits" is the top priority for patients for improving function, quality of life and independence. Building on existing telehealth research, an enhanced home management program (HMP) to leverage and improve patient self-care following liver transplantation was developed, specifically by improving adherence, reducing readmissions and improving the transition from hospital to home. The improvement of care may have profound effect in the first 90 days after transplant on important long-term health parameters that affect clinical outcomes such as depression, weight gain, blood pressure control and diabetes management. With patient engagement, a randomized controlled trial is proposed comparing traditional provider-based care vs. traditional care with HMP. These two arms will need 50 patients in each arm with a 0.5 year follow up. Patients have said that the primary outcomes are quality of life, function and independence. To that end, the primary study outcomes are assessment of adherence, readmissions (90-day), patient satisfaction. The HMP model will advise providers, health care systems, and transplant centers how to improve patient care, especially among those at greatest risk of poor outcomes specifically minorities and those of low socioeconomic status.


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TMITT; Type: ACTIVE_COMPARATOR; Interventions: Other: Transplant Medication Information Teaching Tool | Intervention Type: OTHER; Name: Transplant Medication Information Teaching Tool; Assigned to Arm(s): TMITT
B: Arm Label: 1 with pharmaceutical intervention; Type: EXPERIMENTAL; Interventions: Other: Pharmaceutical Intervention | Arm Label: 2 without pharmaceutical intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmaceutical Intervention; Assigned to Arm(s): 1 with pharmaceutical intervention
C: Arm Label: Prograf®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus - Prograf® twice daily formulation | Arm Label: Advagraf®; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus - Advagraf® once daily formulation | Intervention Type: DRUG; Name: Tacrolimus - Prograf® twice daily formulation; Assigned to Arm(s): Prograf® | Intervention Type: DRUG; Name: Tacrolimus - Advagraf® once daily formulation; Assigned to Arm(s): Advagraf®
D: Arm Label: standard of care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: remote home monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: remote home monitoring | Intervention Type: BEHAVIORAL; Name: remote home monitoring; Assigned to Arm(s): remote home monitoring

Answer: D